Cox-2-inhibitor [Cyclo-oxygenase-2-inhibitors] and Chemotherapy in Non-Small Cell Lung Cancer. A Prospective Randomized Double-Blind Study.
Active, no longer recruiting
Phase of Trial: Phase III
Latest Information Update: 09 Aug 2012
At a glance
- Drugs Celecoxib (Primary)
- Indications Non-small cell lung cancer
- Focus Registrational; Therapeutic Use
- Acronyms CYCLUS
- 31 Aug 2018 Biomarkers information updated
- 07 Jul 2009 Actual patient number (319) added as reported by ClinicalTrials.gov.
- 07 Jul 2009 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History